Treatment of Adult-Onset Immunodeficiency With Bortezomib
Clinical trial NCT03103555 · UNKNOWN
Trial details
- NCT number
- NCT03103555
- Sponsor
- Mahidol University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2018-11-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.